ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Crinetics Pharmaceuticals, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate -237.69% of over the last 5 years
2
The company has declared negative results for the last 25 consecutive quarters
- OPERATING CASH FLOW(Y) Lowest at USD -349.69 MM
- ROCE(HY) Lowest at -44.42%
- OPERATING PROFIT(Q) Lowest at USD -141.57 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -3.52%, its profits have fallen by -52.2%
4
Reducing Promoter Confidence
- Promoters have decreased their stake in the company by -0.75% over the previous quarter and currently hold 6.59% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
5
Underperformed the market in the last 1 year
- Even though the market (S&P 500) has generated returns of 11.87% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -3.52% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Crinetics Pharmaceuticals, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Crinetics Pharmaceuticals, Inc.
-3.52%
-0.42
59.45%
S&P 500
11.87%
0.62
19.30%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
20.49%
EBIT Growth (5y)
-237.69%
EBIT to Interest (avg)
-198.84
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.01
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.64
EV to EBIT
-5.90
EV to EBITDA
-5.94
EV to Capital Employed
-198.65
EV to Sales
1835.22
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-39.46%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
NET PROFIT(HY)
Higher at USD -245.73 MM
NET SALES(9M)
Higher at USD 1.53 MM
CASH AND EQV(HY)
Highest at USD 2,289.65 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 0.44 times
-27What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -349.69 MM
ROCE(HY)
Lowest at -44.42%
OPERATING PROFIT(Q)
Lowest at USD -141.57 MM
PRE-TAX PROFIT(Q)
Lowest at USD -130.09 MM
NET PROFIT(Q)
Lowest at USD -130.09 MM
RAW MATERIAL COST(Y)
Grown by 60,769% (YoY
EPS(Q)
Lowest at USD -1.38
Here's what is working for Crinetics Pharmaceuticals, Inc.
Net Sales
At USD 1.53 MM has Grown at inf%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Cash and Eqv
Highest at USD 2,289.65 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debtors Turnover Ratio
Highest at 0.44 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Net Sales
Higher at USD 1.53 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
Net Sales (USD MM)
Depreciation
Highest at USD 1.01 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Crinetics Pharmaceuticals, Inc.
Pre-Tax Profit
At USD -130.09 MM has Fallen at -69.33%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -130.09 MM has Fallen at -69.33%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Cash Flow
Lowest at USD -349.69 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Operating Profit
Lowest at USD -141.57 MM and Fallen
In each period in the last five periodsMOJO Watch
Near term Operating Profit trend is quite negative
Operating Profit (USD MM)
Pre-Tax Profit
Lowest at USD -130.09 MM and Fallen
In each period in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -130.09 MM and Fallen
In each period in the last five periodsMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
EPS
Lowest at USD -1.38
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
Raw Material Cost
Grown by 60,769% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
